Search results
Results from the WOW.Com Content Network
IQVIA, formerly Quintiles and IMS Health, Inc., [6] is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research.
In May 2016, the company announced it would merge with Quintiles [21] [22] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles.
The U.S. Census Bureau, splits income data into quintiles, which are commonly labeled as different social classes. For the purposes of this article, those with an income in the bottom 20 ...
Gillings is the founder and former chairman of Quintiles, a contract research organization. [6] In 1994, he took Quintiles public through an IPO . [ 6 ] Quintiles is the "largest global provider of clinical trials and commercial marketing services to the pharmaceutical and biotechnology industry". [ 5 ]
Quintiles to Acquire Novella Clinical Acquisition bolsters Quintiles' small biopharma, oncology and medical device capabilities RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE) ...
From January 2008 to December 2012, if you bought shares in companies when Susan B. Bayh joined the board, and sold them when she left, you would have a -30.6 percent return on your investment, compared to a -2.8 percent return from the S&P 500.
In 2008, he became director of Quintiles Transnational Corp, a healthcare company in the field of clinical research. [5] In 2016, Quintiles merged with IMS Health, a health IT company, to become IQVIA. Connaughton became a director of IQVIA in October of that year. [5] Connaughton was appointed to the board of HCA Healthcare for a term through ...
The Royce Consultancy the UK's leading privately held pharmaceutical sales representative recruitment and contract sales organisation (CSO). [1]Royce was founded in 1983 and is the largest healthcare and pharmaceutical recruitment company in the UK.